Breast cancer risk among the survivors of atomic bomb and patients exposed to therapeutic ionising radiation

European Journal of Surgical Oncology

Volumn 29, Issue 5, 2003, Pages 475-479

  Carmichael, A R ^a   Sami, A S ^b   Dixon, J M ^c  

^a PRINCESS ROYAL HOSPITAL   (United Kingdom)

^b DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Breast neoplasms; Epidemiology; Female; Human; Incidence; Ionising; Radiation

Indexed keywords

ARTICLE; ATOMIC BOMB SURVIVOR; BREAST CANCER; BREAST DISEASE; CANCER RISK; FEMALE; FLUOROSCOPY; HIGH RISK POPULATION; HODGKIN DISEASE; HUMAN; IONIZING RADIATION; LUNG TUBERCULOSIS; MASTITIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RISK ASSESSMENT; RISK FACTOR; SKIN HEMANGIOMA; THYMUS DISEASE;

EID: 0038338443     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(03)00010-6     Document Type: Article

References (27)

1. Tokunaga M, Norman JE Jr, Asano M,Tokuoka S, Ezaki H, Nishimori I, Tsuji Y. Malignant breast tumors among atomic bomb survivors Hiroshima and Nagasaki, 1950-74. J Natl Cancer Inst 1979; 62(6): 1347-59.
2. Tokunaga M, Land CE, Tokuoka S, Nishimori I, Soda M, Akiba S. Incidence of female breast cancer among atomic bomb survivors 1950-1985. Radiat Res 1994; 138(2): 209-23.
3. Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, Meadows AT. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996; 334(12): 745-51.
4. Morin DM, Lonstein JE, Stovall M, Hacker DG, Luckyanov N, Land CE. Breast cancer mortality after diagnostic radiography: findings from the U.S. Scoliosis Cohort Study. Spine 2000; 25(16): 2052-63.
5. Boice JD Jr, Land CE, Shore RE, Norman JE, Tokunaga M. Rich or breast cancer following low-dose radiation exposure. Radiology 1979; 131(3): 589-97.
6. Howe GR, McLaughlin J. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian Fluoroscopy Cohort Study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat Res 1996; 145(6): 694-707.
7. Lundell M, Mattsson A, Karlsson P, Holmberg E, Gustafsson A, Holm LE. Breast cancer risk after radiotherapy in infancy: a pooled analysis of two Swedish cohorts of 17,202 infants. Radiat Res 1999; 151 (5): 626-32.
8. Lundell M, Mattsson A, Hakulinen T, Holm LE. Breast cancer after radiotherapy for skin hemangioma in infancy. Radiat Res 1996; 145(2): 225-30.
9. Mattsson A, Ruden BI, Palmgren J, Rutqvist LE. Dose-and time-response for breast cancer risk after radiation therapy for benign breast disease. Br J Cancer 1995; 72(4): 1054-61.
10. Shore RE, Hildreth N, Woodard E, Dvoretsky P, Hempelmann L, Pasternack B. Breast cancer among women given X-ray therapy for acute postpartum mastitis. J Natl Cancer Inst 1986; 77(3): 689-96.
11. Wazer DE, Band V. Molecular and anatomic considerations in the pathogenesis of breast cancer. Radiat Oncol Invest 1999; 7(1): 1-12.
12. Land CE. Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer. JAMA 1995; 274(5): 402-7.
13. Land CE. Radiation and breast cancer risk. Prog Clin Biol Res 1997; 396: 115-24.
14. Land CE, Tokunaga M, Tokuoka S, Nakamura N. Early-onset breast cancer in a-bomb survivors. Lancet 1993; 342(8865): 237.
15. Ban S, Setlow RB, Ezaki H, Hiraoka T, Yamane M, Nishiki M, Dohi K. X-ray sensitivity of fibroblast cell strains derived from atomic bomb survivors with and without breast cancer. J Radiat Res (Tokyo) 1991; 32(Suppl.): 330-8.
16. Korenman SG. The endocrinology of breast cancer. Cancer 1980; 46(4 Suppl.): 874-8.
17. Hoffman DA, Lonstein JE, Morin MM, Visscher W, Harris BS, III, Boice JD Jr. Breast cancer in women with scoliosis exposed to multiple diagnostic X-rays. J Natl Cancer Inst 1989; 81(17): 1307-12.
18. Boice JD Jr, Preston D, Davis FG, Monson RR. Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 1991; 125(2): 214-22.
19. Little MP, Boice JD Jr. Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors. Radiat Res 1999; 151 (2): 218-24.
20. Logan WW, Mansur PS, Cullinan A, Kowaluk E, Hutchings J, Hempleman LH. Increased incidence of breast carcinoma in patients with irradiation for post-partum mastitis: a screening situation. J Surg Oncol 1979; 11(3): 239-42.
21. Hildreth NG, Shore RE, Dvoretsky PM. The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 1989; 321(19): 1281-4.
22. Clemons M, Loijens L, Goss P. Breast cancer risk following irradiation for Hodgkin's Disease. Cancer Treat Rev 2000; 26(4): 291-302.
23. Gaffney DK, Hemmersmeier J, Holden J, Marshall J, Smith LM, Avizonis V, Tran T, Neuhausen SL. Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2. Int J Radiat Oncol Biol Phys 2001; 49(2): 539-46.
24. Feig SA. Radiation risk from mammography: is it clinically significant? Am J Roentgenol 1984; 143(3): 469-75.
25. Jung H. Mammography and radiation risk. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1998; 169(4): 336-43.
26. Mettler FA, Upton AC, Kelsey CA, Ashby RN, Rosenberg RD, Linver MN. Benefits versus risks from mammography; a critical reassessment. Cancer 1996; 77(5): 903-9.
27. Sankaranarayanan K, Chakraborty R. Impact of cancer predisposition and radiosensitivity on the population risk of radiation-induced cancers. Radiat Res 2001; 156: 648-56.